Insulet Corporation Price to Earnings Ratio (PE) Ratios, (PODD) Valuation Ranking and Trends, Fundamental Ratios

PODD Price to Earnings Ratio	(Jun 30 2025)	(Mar 31 2025)	(Dec 31 2024)	(Sep 30 2024)	(Jun 30 2024)
Diluted EPS 12 Trailing Months	II. Quarter	I. Quarter	IV. Quarter	III. Quarter	II. Quarter
PE (TTM) Ratio	current 98.87	47.84	46.21	38.80	35.95
Diluted EPS TTM Y / Y Change	-38.34 %	79.51 %	114.12 %	228.47 %	492.87 %
Diluted EPS Y / Y Change	-87.64 %	-31.51 %	11.22 %	45.95 %	564.1 %
Stock performance	to date 28.55 %	-9.54 %	18.15 %	17.38 %	14.14 %

Price to earnings ratio Comment

Insulet Corporation's current Price to earnings ratio has increased due to shareprice growth of 28.55 %, from beginning of II. Quarter and due to eps contraction of -87.64 %, to Pe of 98.87, from average Price to earnings ratio in I. Quarter of 47.84.

Within Healthcare sector 213 other companies have lower Price to earnings ratio.

What is Price to Earnings Ratio?
What is Insulet Corporation Market Share?

Price to earnings ratio Company Ranking
Within:	No.
Industry	#66
Sector	#214
S&P 500	#2486

Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.